Medical Potential Cannabidiol（CBD）

Recent Court Ruling: A Breakthrough for the Cannabis Industry The recent court ruling represents a significant victory for the hemp and cannabis industries, paving the way for product development and research. Specifically, the legalization of Delta-8 THC marks a pivotal point with potential for industry-wide change, offering new opportunities for market expansion. Medical Potential: Therapeutic […]

Nicotine replacement therapy, NRT is a type of medicine that delivers nicotine to the brain through nasal and oral sprays and inhalers.

At this point in time, with the global legalization of medical marijuana, its medical demand is growing rapidly. It is estimated that the global CBD output value will reach US$22 billion in 2022, a compound growth rate of 57% compared with 2019 (Source: Brightfield Group). According to the use of CBD: it can be divided […]

Global policies are gradually liberalized, and CBD consumption is increasing year by year. According to the use of cannabidiol (CBD): it can be divided into : medical CBD (used to treat epilepsy, Parkinson's disease and other diseases) and, consumer CBD (added to food, new tobacco and other consumer products). At this point in time, with […]

Cannabidiol (CBD) is a chemical substance derived from the cannabis plant, commonly known as marijuana or hemp. A particular type of CBD has been authorized in the United States as a medication for managing epilepsy. The cannabis plant is abundant in over 80 chemicals, collectively known as cannabinoids. Among them, Delta-9-tetrahydrocannabinol (THC) is the most […]

There are some reports that electronic cigarettes can cause some health problems in the lungs.

Inhaling artificial synthetic nicotine can satisfy the demand for nicotine or help quit smoking to a certain extent, and it can also reduce the harm to your own and others' health and the environment.

Several studies have shown that surface e-cigarettes cause damage to DNA .

(1.Shanghai Municipal Center for Health Promotion, Shanghai 200040, China; 2.Shanghai Association of Tobacco Control, Shanghai 200040, China; 3.Shanghai Municipal Health Commission, Shanghai 200125, China)

Department of Pulmonary and Critical Care Medicine, Peking University International Hospital, Beijing 102206, China

Nebulizing inhalation combined with non-invasive ventilation therapy in COPD patients with respiratory failure and nursing．

Aerosol administration during noninvasive ventilation (NIV) is a common clinical drug administration method, but the drug administration efficiency of different drug delivery devices is different.

Nasal aerosol inhalation is increasingly used in intensive care units (ICUs). In pediatric wards in the United States, 75% of patients receive nasal aerosol inhalation therapy, while the rest use traditional nebulization methods.

Nebulizer inhalation can humidify the respiratory tract, reduce inflammation, relieve cough and eliminate phlegm. It can also promote the absorption and excretion of inflammatory secretions. It has few side effects, shortens the course of the disease and has better therapeutic effects.

The study about the factors that affect the effect of nebulized inhalation by HFNC, among which VMN is more suitable for atomization inhalation therapy combined with HFNC.

Study on atomizing suction and atomizing particle size settling position，according to professional research data, the particle size of drug administration atomization into the lung is preferably 2-5 μm.

Here are some useful nebulizer medication guides which about chronic respiratory diseases such as asthma, bronchiectasis, and COPD.

Active smoking or passive exposure to second-hand smoke is one of the main risk factors for chronic obstructive pulmonary disease.

The nebulization process of the mesh nebulizer is gentler and less destructive.